4 Results for "

H3K79 methylation

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "H3K79 methylation" in MCE Product Catalog:

Cat. No.: HY-111589
CAS No.: 1381761-52-9
Research Areas:  

Cancer

EPZ-4777 is a selective DOT1L inhibitor which inhibits H3K79 methylation in cancer cells, blocks the expression of leukemogenic genes, and selectively kills cells that contain the translocation. EPZ-4777 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-181787
CAS No.: 3050756-34-5
Research Areas:  

Cardiovascular Disease

DOT1L705 is a PROTAC degrader that targets DOT1L. DOT1L705 recruits the VHL E3 ubiquitin ligase to induce proteasomal degradation of DOT1L. DOT1L705 reduces the viability of leukemia cells. DOT1L705 inhibits H3K79 methylation. DOT1L705 can be used in studies related to MLL-rearranged leukemia .
loading...
    loading...
Cat. No.: HY-115619
Research Areas:  

Cancer

EPZ004777 formate is an effective and selective DOT1L inhibitor, with IC50 being 0.4 nM. EPZ004777 formate reduces the levels of H3K79me2 and H3K79me1, significantly down-regulating the expression of HOXA9 and MEIS1. EPZ004777 formate selectively inhibits the proliferation of MLL rearrangement cells and promotes the differentiation and subsequent apoptosis (apoptosis) of leukemia cells. EPZ004777 formate can be used for the study of leukemia .
loading...
    loading...
Cat. No.: HY-181789
Research Areas:  

Cancer

DOT1L808 is a potent and highly selective DOT1L PROTAC degrader with a DC50 value of 5 nM. DOT1L808 can promote the ubiquitination and degradation of DOT1L. DOT1L808 exhibits antitumor activity in an orthotopic leukemia model .
loading...
    loading...